# Trade Mark Journal No.2025/043 24 October 2025

## WO0000001881620 (9,42,44)

Office of origin: European Union Intellectual Property Office (EUIPO)

Date of International Registration:10 September 2025
Date of designation in the UK: 10 September 2025

Class 9
  Downloadable software; downloadable software for medical diagnostics; databases; downloadable artificial intelligence software that integrates model data with biomedical data of patients to create a digital twin of a patient; downloadable artificial intelligence software that integrates model data with biomedical data to create a digital twin of a patient; downloadable software for research and analysis of medical and biomedical data; downloadable software for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular, and biomarker data; downloadable software for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; downloadable software for pharmaceutical companies and healthcare providers; downloadable software for developing drugs by simulating patient responses to medications; downloadable software for predicting patient treatment response; databases containing biomedical data.
Class 42
  Research and development services; biomedical research services; platform as a service; software as a service; platforms for artificial intelligence as software as a service featuring software that integrates model data with biomedical data of patients to create a digital twin of a patient; software as a service that integrates model data with biomedical data of a patient to create a digital twin of a patient; platforms for artificial intelligence as software as a service featuring software that integrates model data with biomedical data to create a digital twin of a patient; software as a service that integrates model data with biomedical data to create a digital twin of a patient; platforms for artificial intelligence as software as a service for research and analysis of medical and biomedical data; software as a service for research and analysis of medical and biomedical data; platforms for artificial intelligence as software as a service for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging, and modifying genetic, genomic, molecular and biomarker data; software as a service for gathering, compiling, analyzing, authenticating, validating, controlling, protecting, exchanging and modifying genetic, genomic, molecular and biomarker data; platforms for artificial intelligence as software as a service for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; software as a service for comparing patient biomarker data against genetic, proteomic, and transcriptomic database; platforms for artificial intelligence as software as a service for pharmaceutical companies and healthcare providers; software as a service for pharmaceutical companies and healthcare providers; platforms for artificial intelligence as software as a service for developing drugs by simulating patient responses to medications; software as a service for developing drugs by simulating patient responses to medications; platforms for artificial intelligence as software as a service for predicting patient treatment response; software as a service for predicting patient treatment response; information services relating to research; information services relating to pharmaceutical drug development; information services provided via the internet, namely providing information to pharmaceutical companies to streamline drug discovery and development; providing scientific analysis and informational reports based upon results of genetic, genomic, molecular, and biomarker data.
Class 44
  Healthcare information services; healthcare consultancy services; healthcare services; medical information services provided via the internet, namely providing personalized treatment suggestions to medical professionals tailored after their patients' health profile; medical information services provided via the internet, namely providing medical information to pharmaceutical companies to streamline drug discovery and development; provision of medical information from online databases.

AB MAvatar

Representative: AWA SWEDEN AB, Matrosgatan 1, SE-211 18 Malmö, SWEDEN